Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 27, 2026 06:55 ET | Source: Natural Resource Partners LP

Natural Resource Partners L.P. Reports Fourth Quarter and Full Year 2025 Results and Announces Special Distribution

Natural Resource Partners L.P. Reports Fourth Quarter and Full Year 2025 Results and Announces Special Distribution
February 26, 2026 08:00 ET | Source: 1847 Holdings LLC

1847 Holdings Subsidiary CMD Secures Over $4 Million in New Contracts, Expanding Pipeline to $17.4 Million in Anticipated Q1–Q2 Project Awards

NEW YORK, NY, Feb. 26, 2026 (GLOBE NEWSWIRE) -- 1847 Holdings LLC (OTC: LBRA) (“1847” or the “Company”), a diversified acquisition holding company focused on identifying and monetizing overlooked,...
February 26, 2026 01:00 ET | Source: WENDEL

WENDEL: 2025 Full-Year Results

PRESS RELEASE – FEBRUARY 26, 2026 2025 Full-Year Results In 2025, Wendel accelerated the transformation of its business model: €1591 million of proforma FRE generated by Wendel Investment...
February 26, 2026 01:00 ET | Source: Molecular Partners

Molecular Partners Signs Development Agreement with Eckert & Ziegler for Targeted Alpha Radiotherapeutics

ZURICH-SCHLIEREN, Switzerland and CONCORD, Mass., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a novel class of...
February 25, 2026 16:05 ET | Source: Star Bulk Carriers Corp.

Star Bulk Carriers Corp. Reports Net Profit Of $65.2 Million For The Fourth Quarter Of 2025, And Declares Quarterly Dividend Of $0.37 Per Share

ATHENS, Greece, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Star Bulk Carriers Corp. (the "Company" or "Star Bulk") (Nasdaq: SBLK), a global shipping company focusing on the transportation of dry bulk...
February 25, 2026 07:00 ET | Source: Ovid Therapeutics Inc.

Ovid Therapeutics to Participate in Upcoming Investor Conferences

NEW YORK, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (Nasdaq: OVID), a biopharmaceutical company developing small molecule medicines to treat brain disorders and symptoms caused by...
February 25, 2026 01:30 ET | Source: BUREAU VERITAS

BUREAU VERITAS - Sector-leading organic revenue growth of 6.5% in FY 2025, strong margin improvement to 16.3% in FY 2025, positive growth outlook with continued margin expansion in 2026 and new EUR 200 million share buyback

PRESS RELEASE Courbevoie, France – February 25, 2026 Sector-leading organic revenue growth of 6.5% in FY 2025 Strong margin improvement to 16.3% in FY 2025 Positive growth outlook with continued...
February 24, 2026 11:00 ET | Source: Linnaeus Therapeutics

Linnaeus Therapeutics Awarded Up to $22 Million from ARPA-H to Advance LNS8801 for Healthspan Preservation

HADDONFIELD, N.J., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Linnaeus Therapeutics, Inc., a privately held company focused on the development and commercialization of small molecule therapeutics for...
February 24, 2026 08:30 ET | Source: NewGenIVF Group Limited

NewGen Provides Recap of Strategic Progress as Diversification Fuels Success, Positions Company for Breakout Year

BANGKOK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- NewGenIVF Group (NASDAQ: NIVF) (“NewGen” or the “Company”), a technology-driven, diversified growth company, today outlined its remarkable financial and...
February 24, 2026 07:29 ET | Source: ADW Capital Management, LLC

ADW Capital Management Sends Letter to Compass Diversified’s Board Calling for an Immediate Strategic Review Process and Orderly Liquidation of the Company

Strongly Believes that Structural Discount to Net Asset Value Due to Underperformance and Misalignment of External Manager and Common Shareholders Cannot be Repaired ADW Capital Analysis Supports...